Zika Virus Vaccine Trends and Forecast
The future of the global zika virus vaccine market looks promising with opportunities in the hospital, clinic, and research institute markets. The global zika virus vaccine market is expected to reach an estimated $26.1 billion by 2030 with a CAGR of 5.1% from 2024 to 2030. The major drivers for this market are rising prevelence of zika virus among pregnant women and their babies and ongoing advances in vaccine technology.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Zika Virus Vaccine by Segment
The study includes a forecast for the global zika virus vaccine by type, end use, and region.
Zika Virus Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:
• Therapeutic Vaccines
• Preventive Vaccines
Zika Virus Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Hospitals
• Clinics
• Research Institutes
• Others
Zika Virus Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Zika Virus Vaccine Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies zika virus vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the zika virus vaccine companies profiled in this report include-
• Takeda Pharmaceutical
• NewLink Genetics
• Immunovaccine
• GeneOne Life Science
• GlaxoSmithKline
Zika Virus Vaccine Market Insights
Lucintel forecasts that therapeutic is expected to witness the higher growth over the forecast period.
Within this market, hospital is expected to witness the highest growth.
North America is expected to witness highest growth over the forecast period.
Features of the Global Zika Virus Vaccine Market
Market Size Estimates: Zika virus vaccine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Zika virus vaccine market size by type, end use, and region in terms of value ($B).
Regional Analysis: Zika virus vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the zika virus vaccine market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the zika virus vaccine market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the zika virus vaccine market size?
Answer: The global zika virus vaccine market is expected to reach an estimated $26.1 billion by 2030.
Q2. What is the growth forecast for zika virus vaccine market?
Answer: The global zika virus vaccine market is expected to grow with a CAGR of 5.1% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the zika virus vaccine market?
Answer: The major drivers for this market are rising prevelence of zika virus among pregnant women and their babies and ongoing advances in vaccine technology.
Q4. What are the major segments for zika virus vaccine market?
Answer: The future of the zika virus vaccine market looks promising with opportunities in the hospital, clinic, and research institute markets.
Q5. Who are the key zika virus vaccine market companies?
Answer: Some of the key zika virus vaccine companies are as follows:
• Takeda Pharmaceutical
• NewLink Genetics
• Immunovaccine
• GeneOne Life Science
• GlaxoSmithKline
Q6. Which zika virus vaccine market segment will be the largest in future?
Answer: Lucintel forecasts that therapeutic is expected to witness the higher growth over the forecast period.
Q7. In zika virus vaccine market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the zika virus vaccine market by type (therapeutic vaccines and preventive vaccines), end use (hospitals, clinics, research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Zika Virus Vaccine Market, Zika Virus Vaccine Market Size, Zika Virus Vaccine Market Growth, Zika Virus Vaccine Market Analysis, Zika Virus Vaccine Market Report, Zika Virus Vaccine Market Share, Zika Virus Vaccine Market Trends, Zika Virus Vaccine Market Forecast, Zika Virus Vaccine Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.